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ABSTRACT
Objective: Denguefeveris one of the important tropical disease of public health significance caused by flavivirus. It is a major cause of morbidity and 
mortality worldwide. Identification of factors associated with severity of dengue can improve the prognosis of the disease.This study tried toassess 
the factors associated with severity of dengue.
Methods: A record based study was conducted in a tertiary care hospital setting in southern India. A total of 550 case files were reviewed to ascertain 
demographic, clinical and laboratory parameters among confirmed cases of dengue. The severity of dengue was categorized using WHO 2009 
classification.
Results: Of 550 records reviewed, 449 (81.6%) were classified as non-severe dengue and 101 (18.4%) as severe dengue. Factors associated with 
severe dengue on univariate analysis were: gender, backache, skin rash, nausea and vomiting, abdominal distension, haemorrhage, breathlessness, 
oliguria, hepatomegaly, splenomegaly, ascites, leukopenia, hypoproteinemia, and elevated serum alanine transaminase (ALT) >63 IU/L.On multivariate 
analysis,haemorrhage (OR=11.75, 95%; CI=6.38-21.62), oliguria (OR=4.01, 95%; CI=1.32-12.15), ascites (OR=2.68, 95%; CI=1.19-6.01), ALT>63 IU/L 
(OR=1.77, 95%; CI=1.01-3.1) and hypoproteinemia (OR=5.57, 95%; CI=2.82-10.98) were found to have significant association with the development 
of severe dengue.
Conclusion: This study indicates thatwhen dengue patients present with bleeding episodes, ascites, oliguria,raised ALT and low serum protein levels, 
clinicians should be alert to the appearance of severe complications. Early identification of these factors will help clinicians to recognise the severity 
of dengue illness and enable them to implement appropriate interventions.
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INTRODUCTION
Dengue is a debilitating vector-borne disease with a 30-fold rise in 
disease incidence over the past five decades.According to the World 
Health Organization (WHO), dengue is a major global threat [1]. 
More than 70% of the dengue disease burden is in South-East Asia 
and the Western Pacific. Urbanization, rapid movement of people and 
goods, favourable climatic conditions and lack of trained staff have all 
contributed to the global increase of dengue. An estimated 500000 
people with severe dengue require hospitalization each year, and about 
2.5% of those affected die [2]. In 2015, India has reported about 6280 
deaths due to dengue fever [3].
Dengue infection can present with a wide spectrum of clinical 
manifestations, from a simple febrile illnessto severe features of plasma 
leakage leading to shock [1].The factors associated with severe dengue 
such as age >40 years, male gender, secondary infection, presence of 
abdominal pain, persistent vomiting, bleeding, raised haematocrit, 
lymphopenia, high AST or ALT levels by more than 3 times the upper 
limit of normal and hypoproteinemia by using either the 1997 or 2009 
WHO definition has been well described but with varying results [4-7].
Based on this background, this study was designed to identify thefactors 
associatedwith the dengue severity by using the WHO 2009 definition. 
Additionally, this study will provide an overview on the demographics 
as well as clinical and laboratory profile of the individuals affected with 
dengue.
METHODS
A total of 550patient’s medical records diagnosed as dengue feverwere 
reviewed ata tertiary care teaching hospital in south India.Both male 
and female subjects, ≥18 years admitted to medical wards with positive 
serology for dengue infection confirmedby either dengue IgM ELISA or 
non-structural protein 1 (NS1) antigen test were included in the study. 
Presence of concomitant febrile illnesses along with dengue such as 
malaria, scrub typhus, typhoid and leptospirosis were excluded.The 
following information related todemography,clinical characteristics, 
laboratory results; complications associated with dengue fever 
andadministered treatment was documented in a structured 
questionnaire.
The World Health Organization (WHO) 2009 classification of dengue [1] 
was used to group the patients into non-severe dengue (NSD)and severe 
dengue (SD).AKI was defined as increased serum creatinine >1.5 times 
from the baselineor a decreased urine output of<0.5 ml/kg/hour 
for  6 hours.The study protocol was approved by the Institutional 
Ethical Committee (IEC) and since the study was retrospective, written 
informed consent was not required.
Statistical analyses were carried out using SPSS 16.0. Frequency 
and percentage was used to summarize categorical variables while 
mean±SD or median (IQR) was used to summarize continuous variables. 
Chi square test was used to find association between categorical 
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exposure variables (clinical, demographic and laboratory) with severe 
dengue. Independent sample t-test (Mann-Whitney U test) was used 
to compare mean (median) of continuous exposure variables (clinical, 
demographic and laboratory) with severe dengue. Logistic regression 
analysis was used to find factors associated withsevere dengue. All 
variables with p<0.2 on univariate analysis were considered for logistic 
regression analysis. Backward Wald elimination procedure was used 
to select significant variables. A p value of <0.05 was considered as 
statistically significant.
RESULTS
A total of 550 patient’s medical records were reviewed. Out of 
which 405 (73.6%) were males and 145 (26.4%) were females. 
The male  to  female ratio was 2.8:1. The most affected age group 
was  21- 30 years followed by 31- 40 years. The mean age of the patients 
was 32.41 (SD=11.64) years. There was no statistically significant 
difference observed in mean age between the two groups. Majority of 
the patients were working in agriculture setting (114/550) 20.7%.
Clinical characteristics in patients with dengue fever are described in 
Table 1. Fever was the most consistent complaint 547 (99.5%) followed 
by headache 263 (47.8%), myalgia 241 (43.8%), vomiting  227 (41.3%) 
and pain abdomen 165 (30%).Haemorrhagemanifested in 79 (14.4%) 
cases in the form of: petechiae 35 (6.4%);melena 18 (3.3%); 
hematemesis 8 (1.5%); gum bleed13 (2.4%); epistaxis 4 (0.7%); 
haematuria 9 (1.6%); and menorrhagia 7 (4.8%). Some patients 
presented with more than one haemorrhagic manifestation.
Twenty-nine (5.3%) patients had shock as the predominant complication 
followed by AKI (4.2%).Acute hepatitis with aminotransferase levels 
increased to at least 10 times their normal values was observed 
in 16 (2.9%) cases.All patients with acute respiratory distress syndrome 
(ARDS)required ventilator support. Of these, eight patients improved 
and were successfully weaned off the ventilator.
Rapid decline in WBC and platelet counts were frequently noted in the 
early phase of the disease.Large number of patients had a platelet count 
of less than 50,000/mm3 (Table 2). Further, the prevalence of bleeding 
episodes among patients with platelet count <50,000/mm3 was 
significantly higher (p=0.001) among SD group (22/60) as compared 
to NSD group (29/225). Therise in transaminase levels was commonly 
observed and in most cases, there was a greater elevation in AST than 
ALT levels. The salient laboratory findings are summarized in Table 3. 
Antipyretics (oral paracetamol) were used along with intravenous fluids 
when required. Platelet transfusion was done in 103 (18.7%) patients 
with low platelet counts and bleeding during hospitalization. Packed 
red blood cells were transfused in 12 caseswith anaemiaand bleeding 
episodes. The median duration of hospitalization was 5 days (IQR, 
4-6 days) in mostcases. Fifty-four (9.8%) patients required admission 
to intensive care units (ICU).The mortality was observed in 7 (1.3%) 
and all fatal cases were due to shock, ARDS and multi-organ failure.
The results of multivariate logistic regression analysis for factors 
associated with severe dengue are presented in Table 4. From 
univariate analysis of clinical, demographic and laboratory parameters, 
we found that gender, backache, skin rash, nausea and vomiting, 
abdominal distension, haemorrhage, breathlessness, oliguria, 
hepatomegaly, splenomegaly, ascites, leukopenia, hypoproteinemia 
and high ALTshowed significant association with severe dengue. 
The corresponding unadjusted Odd’s ratio ranges from 0.4 to 7.93. 
After taking into consideration all these variables for binary logistic 
regression analysis, skin rash, haemorrhagic episodes, oliguria, low 
serum protein, high ALT and ascites were found to be associated 
with severe disease. The corresponding adjusted Odd’s ratio ranges 
from 0.42 to 11.75. The risk of severe dengue was more among 
patients who had haemorrhage (OR=11.75, 95%; CI=6.38-21.62), 
oliguria(OR=4.01,95%;CI=1.32-12.15),ascites(OR=2.68, 95%; CI=1.19-
6.01),hypoproteinemia (OR=5.57, 95%; CI=2.82-10.98) and high ALT 
(OR=1.77, 95%; CI=1.01-3.1).
DISCUSSION
The existing global distribution of the risk of dengue virus infection and 
its complications are now becoming prevalent and severe. Additionally, 
the changing epidemiology and rapid urbanization in developing 
countries such as India has enormously increased the prevalence of 
life threatening diseases like dengue [8].Frequent outbreaks of dengue 
fever havebeen reported over the last few decades with large number of 
patients presenting with atypical features such as pancreatitis, myositis, 
serositis, myocarditis, hepatitis, acalculous cholecystitis, central 
nervous system involvement, and even death [9,10]. Given the wide 
range of clinical manifestations of dengue fever, one of the challenges to 
the treating clinician is to be able to identify which patients are likely to 
develop severe dengue. Early recognition of factors associated with the 
severity of dengue will help identify the patients with severe infection.
Table 1: Demographic and clinical profile of dengue infection
Patient characteristics Total (n=550) Dengue with or without warning signs (n=449) SD (n=101) p
Male 405 (73.6) 342 (76.2) 63 (62.4) 0.004*
Female 145 (26.4) 107 (23.8) 38 (37.6)
Age (years)# 32.41±11.64 31.96±11.51 34.39±12.04 0.058
Fever 547 (99.5) 447 (99.6) 100 (99.0) 0.502
Headache 263 (47.8) 223 (49.7) 40 (39.6) 0.067
Myalgia 241 (43.8) 198 (44.1) 43 (42.6) 0.780
Arthralgia 98 (17.8) 81 (18.0) 17 (16.8) 0.774
Backache 35 (6.4) 32 (7.1) 3 (3.0) 0.122
Pain abdomen 165 (30.0) 133 (29.6) 32 (31.7) 0.683
Abdominal distension 30 (5.5) 18 (4.0) 12 (11.9) 0.002*
Nausea and vomiting 227 (41.3) 177 (39.4) 50 (49.5) 0.063
Hemorrhage 79 (14.4) 37 (8.2) 42 (41.6) <0.001*
Breathlessness 13 (2.4) 6 (1.3) 7 (6.9) 0.001*
Oliguria 19 (3.5) 8 (1.8) 11 (10.9) <0.001*
Conjunctival congestion 94 (17.1) 79 (17.6) 15 (14.9) 0.508
Skin rash 170 (30.9) 145 (32.3) 25 (24.8) 0.138
Hepatomegaly 62 (11.3) 42 (9.4) 20 (19.8) 0.003*
Splenomegaly 32 (5.8) 23 (5.1) 9 (8.9) 0.142
Pleural effusion 13 (2.4) 8 (1.8) 5 (5.3) 0.038*
Ascites 44 (8) 27 (6.0) 17 (16.8) <0.001*
SBP (mmHg)# 119±14 120±12 115±19 0.001*
DBP (mmHg)# 77±12 78±9 72±21 <0.001*
#Data are expressed as mean±SD, SD: Standard deviation, SBP: Systolic blood pressure, DBP: Diastolic blood pressure. *p<0.05. SD: Severe dengue
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Although no difference in the gender distribution of dengue cases exist, 
several studies have reported varying results.In the majority of reports 
of dengue outbreaks in India, males outnumbered females [11,12].This 
gender difference in dengue cases may be due to increased mobility of 
male population in the society and better access to health-care [13]. 
However, our study did not find gender as a risk of dengue infection 
severity.Dengue virus infections affect human populations of all age 
groups worldwide. In some parts of the world, dengue is mainly a 
paediatric health problem[1]. In this study, majority of cases were 
seen in the 21-30 years’ age group which supports the observations 
made by some authors who reported that dengue infection in India is 
predominantly a disease of young adults [14,15].
The classical symptoms of dengue infectionsuch asfever,headache,and 
pain abdomen with vomiting were observed in majority of cases.
Althoughbleedingin the form of petechiae and melena was seen in many 
patients, none of our patients had severe haemorrhage.Bleeding in 
severe dengue infection may be related to impaired platelet function with 
moderate to severe thrombocytopenia and coagulopathy, with activation 
of the coagulation system and fibrinolysis [16]. Fluid accumulation due 
to plasma leakage including ascites and pleural effusion was noted in 8% 
and 2.4% of patients on ultrasound scan of abdomen while acalculous 
cholecystitis was noted in only 5 cases.Presence of ascites and/or pleural 
effusion and its correlation with disease severity is well documented 
in the previous studies, but the association of acalculous cholecystitis 
with severe dengue is yet to be understood [17,18].In this study, ascites 
wasfound to be associated with severity.
Clinical evidence includes hepatomegaly, with liver involvement being 
more frequentin the severe form of disease [19]. Hepatomegalywas 
found to be a strong risk factor for severe dengue in many studies 
in the past [20,21], however, our study did not find hepatomegaly as 
a risk for dengue infection severity. Though splenomegaly is not a 
common feature in dengue fever itwas noted in 5.8% of patients. In 
the current study, we did not find statistically significant association 
of splenomegaly with severe illness. In a recently published report 
from Pakistan, it was observed that significant number of patients 
with severe dengue had splenomegaly [22]. The reason for spleen 
enlargement in severe dengue infection may be due to replication of 
dengue virus in spleen, resulting in splenomegaly [23]. These clinical 
findings emphasize the fact that presence of hepatomegaly and ascites 
in addition to with or without splenomegaly in a patient with dengue 
infection should prompt a clinician to suspect severe illness and manage 
severity early in the course of the illness.
Table 3: Clinical investigations among dengue fever patients
Investigations Dengue with or without warning signs (n=449) mean±SD SD (n=101) mean±SD p
Hemoglobin (g/dL) 14.7±1.9 14.3±2.6 0.001*
Hematocrit (%) 44.2±5.7 42.7±7.8 0.097
White cell count (/µL)# 5200 (3500–8100) 6200 (4200–9450) 0.120
Leukopenia (n, %) 144 (32.1) 22 (21.8) 0.042*
Lymphocytes (%) 36.6±16.3 30.4±15.2 0.632
Platelets (/µL)# 47,000 (21,000–87,000) 37,000 (15,000–83,000) 0.797
Total bilirubin (mg/dL)# 0.5 (0.4–0.8) 0.7 (0.4–1.3) <0.001*
Direct bilirubin (mg/dL)# 0.2 (0.1–0.3) 0.3 (0.2–0.8) <0.001*
Total protein (g/dL) 6.8±0.7 6.4±0.8 0.002*
Hypoproteinemia (n, %) (<6 g/dL) 37 (8.2) 31 (30.7) <0.001*
Serum albumin (g/dL) 3.8±0.5 3.5±0.6 <0.001*
Hypoalbuminemia (n, %) (<3.5 g/dL) 78 (17.4) 43 (42.6) <0.001*
AST (>40 IU/L) (n, %) 412 (91.8) 94 (93.1) 0.620
ALT (>63 IU/L) (n, %) 259 (57.7) 70 (69.3) 0.026*
#Data are expressed as median, IQR: interquartile range, SD: Standard deviation, AST: Aspartate transaminase, ALT: Alanine transaminase, *p<0.05. SD: Severe dengue
Table 4: Multivariable analysis of factors for acquiring SD
Variables Unadjusted OR (95% CI) Adjusted OR (95% CI) p value for adjusted OR
Sex (female) 1.93 (1.22–3.05)
Backache 0.4 (0.12–1.33)
Skin rash 0.69 (0.42–1.13) 0.42 (0.23–0.78) 0.005*
Nausea and vomiting 2.01 (1.09–3.72)
Abdominal distension 3.23 (1.5–6.94)
Hemorrhage 7.93 (4.72–13.32) 11.75 (6.38–21.62) 0.014*
Breathlessness 5.5 (1.81–16.73)
Oliguria 6.74 (2.64–17.22) 4.01 (1.32–12.15) 0.001*
Leukopenia 0.59 (0.35–0.99)
Hypoproteinemia 4.93 (2.87–8.47) 5.57 (2.82–10.98) 0.001*
High ALT 1.69 (1.06–2.7) 1.77 (1.01–3.1) 0.048*
Hepatomegaly 2.39 (1.34–4.29)
Splenomegaly 1.81 (0.81–4.04)
Ascites 3.16 (1.65–6.06) 2.68 (1.19–6.01) 0.017*
*p<0.05. SD: Severe dengue, ALT: Alanine transaminase, CI: Confidence interval, OR: Odd’s ratio
Table 2: Platelet counts in patients with dengue fever
Total (n=550) Dengue with or without warning signs (n=449) SD (n=101) p value
<20,000 133 (24.2) 97 (21.6) 36 (35.6) 0.004*
<50,000 285 (51.8) 225 (50.1) 60 (59.4) 0.118
50,000–100,000 154 (28.0) 132 (29.4) 22 (21.8) 0.107
100,000–150,000 54 (9.8) 45 (10.0) 9 (8.9) 0.705
*p<0.05. SD: Severe dengue
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Asignificant number of patients (5.3%) had shock in the present series. 
Leo et al., conducted a 5-year retrospective study in Singapore on 
confirmed adult dengue fatalities and found that deaths among dengue 
cases were due to shock (100%) and organ failure (85.7%) [24]. 
Prolonged shock in severe dengue is most often complicated by 
metabolic acidosis, multi-organ impairment and severe bleeding which 
carries a poor prognosis [16].
Hepatic dysfunction is a well-recognized feature of dengue infection, 
often demonstrated by hepatomegaly and mild-to-moderate increases 
in transaminase levels although jaundice and acute hepatitis are 
uncommon.The liver dysfunction in dengue infection can be a result 
of the direct effect of the virus on liver cells or the dysregulated host 
immune response against the virus [19,25].The present study showed 
AST>ALT which is consistent with the observations made by Kuo et al. in 
an evaluation of 270 dengue patients, observed abnormal levels of AST 
and ALT in 93.3% and 82.2% respectively. They reported that elevation 
of AST levels was usually greater than ALT [26]. This may be due to the 
release of AST during myocyte damage in dengue infection.However, 
on regression analysis, we noticed that raised ALT was independently 
associated with severe disease. ALT is primarily associated with 
hepatocytes, with minimal activity in kidney and skeletal muscle. It is 
possible that raised ALT in severe dengue may reflect both liver and 
renal dysfunction.
The sinister symptom that points to renal dysfunction such as oliguria 
was observed in 19 (3.5%) cases with AKI (n=23, 4.2%). It was noted to 
be associated with severe illness and in majority it was self-limited.The 
proposed mechanisms include increased plasma leakage and loss of 
fluid from the intravascular compartment leading to shock which may 
lead to reduced renal perfusion and acute tubular necrosis [27].
We observed that serum protein levels were associated with severe 
dengue, whereas haematocrit,platelet count, leukocyte count and 
serum albumin were not. In addition to hypoproteinemia, we found that 
raised ALT levels were associated with severe form ofdisease. This is in 
contrast to observations made by Jayaratne et al.,stated that raised AST 
levels were associated with severe dengue and have better predictive 
value in predicting severe disease [28]. Ours findings indicate that 
in addition to evaluating hemoconcentration and decreased platelet 
counts, the presence of low serum protein and raised ALT levels may be 
taken as a marker for predicting severe disease.
Our study had some limitations such as only hospitalized patients with 
dengue fever were included in this study and secondly, few studies are 
available pertaining to factors associated with severe dengue based 
on the 2009 WHO classification. In the 1997 WHO classification, DHF 
and DSS comprise the severe form of the disease. Due to differences in 
the variables included in each classification, comparing the results of 
the present study with the WHO 1997 classification may not be much 
justifiable.
CONCLUSION
Based on the results, we conclude that bleeding episodes, ascites, 
oliguria, raised ALT and low serum protein levels were associated with 
severe illness. When dengue patients present with these features, the 
clinician should be aware of the possibility of severe complications. Early 
identification of factors associated with dengue severity is important 
for the clinicians in order to implement appropriate interventions for 
better prognosis.
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